Geron Corp (GERN), Janssen Pharma Enter Exclusive Licensing Agreement
Tweet Send to a Friend
Geron Corp (Nasdaq: GERN) disclosed the following in a U.S. SEC filing on Monday:Item 1.01 Entry into a Material Definitive ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
